Literature DB >> 20450314

A case of lymphedema-distichiasis syndrome carrying a new de novo frameshift FOXC2 mutation.

Antonella Fabretto1, Alison Shardlow, Flavio Faletra, Loredana Lepore, Uros Hladnik, Paolo Gasparini.   

Abstract

PURPOSE: Lymphedema-Distichiasis (LD, OMIM 153400) is an autosomal dominant disorder with variable expression. The mutated gene implicated is FOXC2, which encodes for a forkhead transcription factor involved in the development of the lymphatic and vascular system. LD is characterized by late childhood or pubertal onset lymphedema of the limbs and distichiasis. Other associations have been reported, including congenital heart disease, ptosis, scoliosis.
CONCLUSIONS: Here we describe a case of LD carrying a de novo frameshift mutation of FOXC2 who presented a prepubertal onset of lower limbs lymphedema and mild distichiasis associated with other anomalies such as webbing neck and ptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20450314     DOI: 10.3109/13816811003620517

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  3 in total

Review 1.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

2.  [Genetic analysis and clinical phenotype of a family with lymphedema-distichiasis syndrome].

Authors:  Gang Hu; Bei Liu; Min Chen; Yeqing Qian; Minyue Dong
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-10-25

3.  FOXC2 mutations in familial and sporadic spinal extradural arachnoid cyst.

Authors:  Yoji Ogura; Shoji Yabuki; Aritoshi Iida; Ikuyo Kou; Masahiro Nakajima; Hiroki Kano; Masaaki Shiina; Shinichi Kikuchi; Yoshiaki Toyama; Kazuhiro Ogata; Masaya Nakamura; Morio Matsumoto; Shiro Ikegawa
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.